An expert industry observer said CVS Health's move into primary care is both offensive and defensive, but perhaps more importantly a natural evolution of a company with such a large healthcare footprint.
Payers are increasingly leveraging collaborative partnerships to develop AI models designed to improve early intervention for high risk patients. Health insurers are also interested in collaborating with providers to expand virtual care to not only provide more flexibility to members, but to also provide more effective platforms for triaging patients when they need care.
As part of itsEnvision U.S. Healthcare Summit, Microsoft conducted interviews with executives at Aetna CVS Health and Humana to highlight some of the ways these companies are adapting to consumerization of healthcare.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. This is your chance to save $100 with the Early Bird Rate (Ends 8/26).
Clinicians used to wonder if there was a role for mindfulness meditation in healthcare. But after the Covid-19 pandemic laid bare the overwhelming need for practical solutions in behavioral health, the question has shifted to what role it can play.
GSK is partnering with Mersana Therapeutics on the development of an antibody-drug conjugate that is approaching Phase 1 testing. Unlike other ADCs that deliver a toxic drug payload, the Mersana drug is designed to activate the innate immune system to fight tumor cells.
The number of in-network behavioral health providers increased by 48% in the last three years among commercial health plans. The number of in-network inpatient psychiatric hospitals rose by 40%.
Medical technology startup Sibel Health recently closed a $33 million Series B funding round. It will use the funds to grow the company and scale commercialization of its Anne One platform, which captures users' vital signs using wearable sensors.
Pfizer's own R&D efforts in sickle cell disease have fallen short, so the pharmaceutical giant is turning to M&A to gain a presence in the blood disorder. The acquisition of Global Blood therapeutics brings the commercialized drug Oxbryta plus a pipeline of other therapeutic candidates.
Payers, providers, financial institutions and tech innovators – often known as "frenemies" – need to set aside their old competitive spirit and come together as one team for the healthcare industry to be truly interoperable.
Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively.
Post Comment
No comments